Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lipocine (LPCN) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for Lipocine (LPCN) over the last 12 years, with Q3 2025 value amounting to 0.4%.

  • Lipocine's Return on Invested Capital fell 1400.0% to 0.4% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.4%, marking a year-over-year decrease of 1400.0%. This contributed to the annual value of 0.05% for FY2024, which is 5900.0% up from last year.
  • Lipocine's Return on Invested Capital amounted to 0.4% in Q3 2025, which was down 1400.0% from 0.31% recorded in Q2 2025.
  • Lipocine's Return on Invested Capital's 5-year high stood at 0.08% during Q3 2022, with a 5-year trough of 0.84% in Q4 2023.
  • Moreover, its 5-year median value for Return on Invested Capital was 0.36% (2021), whereas its average is 0.31%.
  • Its Return on Invested Capital has fluctuated over the past 5 years, first surged by 11000bps in 2021, then tumbled by -7800bps in 2023.
  • Over the past 5 years, Lipocine's Return on Invested Capital (Quarter) stood at 0.08% in 2021, then plummeted by -534bps to 0.33% in 2022, then plummeted by -153bps to 0.84% in 2023, then skyrocketed by 94bps to 0.05% in 2024, then plummeted by -658bps to 0.4% in 2025.
  • Its last three reported values are 0.4% in Q3 2025, 0.31% for Q2 2025, and 0.32% during Q1 2025.